FilingSEC EDGAR6-K
Galmed Pharmaceuticals Approves All Proposals at Annual General Meeting
· SEC accepted
StageShareholder Meeting Results
Filing content
Galmed Pharmaceuticals announced that shareholders approved all proposals at the Annual General Meeting held on September 3, 2026.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…